focus
Previous article:
Apple is now the first public company to be valued at $3 trillion
Next article: The tragedy of Johnson & Johnson’s Covid vaccine
Next article: The tragedy of Johnson & Johnson’s Covid vaccine
focus
focus
-
For longer
2025-09-28 02:24 -
ASCO eve: Let’s set the table for this year's meeting
2025-09-28 02:16 -
Research misconduct: Proposed new rules face resistance
2025-09-28 02:14 -
Eyeing GLP
2025-09-28 01:49 -
Biogen joins immunology wave with $1.15 billion acquisition of HI
2025-09-28 00:32 -
eGenesis tests gene
2025-09-28 00:27